High-risk prostate cancer: the role of radical prostatectomy for local therapy

被引:0
作者
Ghavamian, Reza [1 ]
Williams, Steve K. [1 ]
Hakimi, A. Ari [1 ]
机构
[1] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Urol, Bronx, NY 10583 USA
关键词
high-risk prostate cancer; outcomes; prostate cancer; prostatectomy; radiation therapy; RETROPUBIC PROSTATECTOMY; ADJUVANT RADIOTHERAPY; RADIATION-THERAPY; CLINICAL STAGE; MEN; SURVIVAL; ANTIGEN; IMPACT; PROGRESSION; CARCINOMA;
D O I
10.2217/FON.11.22
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The management of high-risk prostate cancer can pose a unique challenge to the urologic oncologist. High-risk prostate cancer remains a real entity, especially in the inner-city urban population centers with high-risk ethnic groups. Although the role of radical prostatectomy is well defined for localized, low-to-intermediate-risk prostate cancer, its role in high-risk disease is more controversial. This is compounded by a lack of a universally accepted definition for 'high-risk disease and the stage migration that has occurred in prostate cancer in the PSA era, rendering some historical perspectives less relevant. However, what has been accepted is the role of multimodal therapy in the management of this challenging group of patients. This article offers the reader an up-to-date detailed review of this topic, with specific emphasis on the role of radical prostatectomy in this clinical setting, including surgical considerations and outcomes. The advantages in terms of accurate pathologic staging with radical prostatectomy are presented. The role of robotic radical prostatectomy, which is increasingly utilized in the USA for the surgical treatment of prostate cancer in this clinical scenario, is discussed. In addition, we address the shortcomings of adequate clinical staging in this group of patients and discuss advances in imaging that might improve our capabilities in the future.
引用
收藏
页码:543 / 550
页数:8
相关论文
共 48 条
[1]   Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer [J].
Albertsen, PC ;
Hanley, JA ;
Gleason, DF ;
Barry, MJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (11) :975-980
[2]   13-year outcomes following treatment for clinically localized prostate cancer in a population based cohort [J].
Albertsen, Peter C. ;
Hanley, James A. ;
Penson, David F. ;
Barrows, George ;
Fine, Judith .
JOURNAL OF UROLOGY, 2007, 177 (03) :932-936
[3]   Oncologic control obtained after radical prostatectomy in men with a pathological Gleason score ≥ 8: A single-center experience [J].
Audenet, Francois ;
Comperat, Eva ;
Seringe, Elise ;
Drouin, Sarah J. ;
Richard, Francois ;
Cussenot, Olivier ;
Bitker, Marc-Olivier ;
Roupret, Morgan .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2011, 29 (06) :602-607
[4]   Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial [J].
Bolla, M ;
Collette, L ;
Blank, L ;
Warde, P ;
Dubois, JB ;
Mirimanoff, RO ;
Storme, G ;
Bernier, J ;
Kuten, A ;
Sternberg, C ;
Mattelaer, J ;
Torecilla, JL ;
Pfeffer, JR ;
Cutajar, CL ;
Zurlo, A ;
Pierart, M .
LANCET, 2002, 360 (9327) :103-108
[5]   Surgical management of high risk prostate cancer: The Mayo Clinic experience [J].
Boorjian, Stephen A. ;
Blute, Michael L. .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2008, 26 (05) :530-532
[6]   Long-term outcome following radical prostatectomy in men with clinical stage T3 prostate cancer [J].
Carver, Brett S. ;
Bianco, Fernando J., Jr. ;
Scardino, Peter T. ;
Eastham, James A. .
JOURNAL OF UROLOGY, 2006, 176 (02) :564-568
[7]   Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer [J].
D'Amico, AV ;
Whittington, R ;
Malkowicz, SB ;
Schultz, D ;
Blank, K ;
Broderick, GA ;
Tomaszewski, JE ;
Renshaw, AA ;
Kaplan, I ;
Beard, CJ ;
Wein, A .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (11) :969-974
[8]   Trends and predictors of aggressive therapy for clinical locally advanced prostate carcinoma [J].
Denberg, Thomas D. ;
Glode, L. Michael ;
Steiner, John F. ;
Crawford, E. David ;
Hoffman, Richard M. .
BJU INTERNATIONAL, 2006, 98 (02) :335-340
[9]   Poorly differentiated prostate cancer treated with radical prostatectomy: Long-term outcome and incidence of pathological downgrading [J].
Donohue, John F. ;
Bianco, Fernando J., Jr. ;
Kuroiwa, Kentaro ;
Vickers, Andrew J. ;
Wheeler, Thomas M. ;
Scardino, Peter T. ;
Reuter, Victor A. ;
Eastham, James A. .
JOURNAL OF UROLOGY, 2006, 176 (03) :991-995
[10]  
Donovan J, 2003, Health Technol Assess, V7, P1